Human trisomy 21 fibroblasts rescue methotrexate toxic effect after treatment with 5‐methyl‐tetrahydrofolate and 5‐formyl‐tetrahydrofolate

Trisomy 21 causes Down syndrome (DS), the most common human genetic disorder and the leading genetic cause of intellectual disability. The alteration of one‐carbon metabolism was described as the possible metabolic cause of the intellectual disability development in subjects with DS. One of the bioc...

Full description

Saved in:
Bibliographic Details
Published inJournal of cellular physiology Vol. 234; no. 9; pp. 15010 - 15024
Main Authors Vitale, Lorenza, Serpieri, Valentina, Lauriola, Mattia, Piovesan, Allison, Antonaros, Francesca, Cicchini, Elena, Locatelli, Chiara, Cocchi, Guido, Strippoli, Pierluigi, Caracausi, Maria
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.09.2019
Subjects
Online AccessGet full text
ISSN0021-9541
1097-4652
1097-4652
DOI10.1002/jcp.28140

Cover

Loading…
Abstract Trisomy 21 causes Down syndrome (DS), the most common human genetic disorder and the leading genetic cause of intellectual disability. The alteration of one‐carbon metabolism was described as the possible metabolic cause of the intellectual disability development in subjects with DS. One of the biochemical pathways involved in the one‐carbon group transfer is the folate cycle. The cytotoxic drug methotrexate (MTX) is a folic acid (FA) analogue which inhibits the activity of dihydrofolate reductase enzyme involved in the one‐carbon metabolic cycle. Trisomy 21 cells are more sensitive to the MTX effect than euploid cells, and in 1986 Jérôme Lejeune and Coll. demonstrated that MTX was twice as toxic in trisomy 21 lymphocytes than in control cells. In the present work, the rescue effect on MTX toxicity mediated by FA and some of its derivatives, tetrahydrofolate (THF), 5‐formyl‐THF, and 5‐methyl‐THF, in both normal and trisomy 21 skin fibroblast cells, was evaluated. A statistically significant rescue effect was obtained by 5‐formyl‐THF, 5‐methyl‐THF, and their combination, administered together with MTX. In conclusion, trisomy 21 fibroblast cell lines showed a good response to the rescue effects of 5‐formyl‐THF and 5‐methyl‐THF on the MTX toxicity almost as normal cell lines. Alteration of one‐carbon metabolism might be a metabolic cause of intellectual disability in Down syndrome. Folate cycle is a one‐carbon group transfer pathway. The rescue effect on methotrexate (MTX) toxicity mediated by folates: folic acid, tetrahydrofolate (THF), 5‐formyl‐THF, and 5‐methyl‐THF, in both normal and trisomy 21 skin fibroblast cells was evaluated. A statistically significant rescue effect was obtained by 5‐formyl‐THF, 5‐methyl‐THF, and their combination, when administered with MTX.
AbstractList Trisomy 21 causes Down syndrome (DS), the most common human genetic disorder and the leading genetic cause of intellectual disability. The alteration of one‐carbon metabolism was described as the possible metabolic cause of the intellectual disability development in subjects with DS. One of the biochemical pathways involved in the one‐carbon group transfer is the folate cycle. The cytotoxic drug methotrexate (MTX) is a folic acid (FA) analogue which inhibits the activity of dihydrofolate reductase enzyme involved in the one‐carbon metabolic cycle. Trisomy 21 cells are more sensitive to the MTX effect than euploid cells, and in 1986 Jérôme Lejeune and Coll. demonstrated that MTX was twice as toxic in trisomy 21 lymphocytes than in control cells. In the present work, the rescue effect on MTX toxicity mediated by FA and some of its derivatives, tetrahydrofolate (THF), 5‐formyl‐THF, and 5‐methyl‐THF, in both normal and trisomy 21 skin fibroblast cells, was evaluated. A statistically significant rescue effect was obtained by 5‐formyl‐THF, 5‐methyl‐THF, and their combination, administered together with MTX. In conclusion, trisomy 21 fibroblast cell lines showed a good response to the rescue effects of 5‐formyl‐THF and 5‐methyl‐THF on the MTX toxicity almost as normal cell lines.
Trisomy 21 causes Down syndrome (DS), the most common human genetic disorder and the leading genetic cause of intellectual disability. The alteration of one-carbon metabolism was described as the possible metabolic cause of the intellectual disability development in subjects with DS. One of the biochemical pathways involved in the one-carbon group transfer is the folate cycle. The cytotoxic drug methotrexate (MTX) is a folic acid (FA) analogue which inhibits the activity of dihydrofolate reductase enzyme involved in the one-carbon metabolic cycle. Trisomy 21 cells are more sensitive to the MTX effect than euploid cells, and in 1986 Jérôme Lejeune and Coll. demonstrated that MTX was twice as toxic in trisomy 21 lymphocytes than in control cells. In the present work, the rescue effect on MTX toxicity mediated by FA and some of its derivatives, tetrahydrofolate (THF), 5-formyl-THF, and 5-methyl-THF, in both normal and trisomy 21 skin fibroblast cells, was evaluated. A statistically significant rescue effect was obtained by 5-formyl-THF, 5-methyl-THF, and their combination, administered together with MTX. In conclusion, trisomy 21 fibroblast cell lines showed a good response to the rescue effects of 5-formyl-THF and 5-methyl-THF on the MTX toxicity almost as normal cell lines.Trisomy 21 causes Down syndrome (DS), the most common human genetic disorder and the leading genetic cause of intellectual disability. The alteration of one-carbon metabolism was described as the possible metabolic cause of the intellectual disability development in subjects with DS. One of the biochemical pathways involved in the one-carbon group transfer is the folate cycle. The cytotoxic drug methotrexate (MTX) is a folic acid (FA) analogue which inhibits the activity of dihydrofolate reductase enzyme involved in the one-carbon metabolic cycle. Trisomy 21 cells are more sensitive to the MTX effect than euploid cells, and in 1986 Jérôme Lejeune and Coll. demonstrated that MTX was twice as toxic in trisomy 21 lymphocytes than in control cells. In the present work, the rescue effect on MTX toxicity mediated by FA and some of its derivatives, tetrahydrofolate (THF), 5-formyl-THF, and 5-methyl-THF, in both normal and trisomy 21 skin fibroblast cells, was evaluated. A statistically significant rescue effect was obtained by 5-formyl-THF, 5-methyl-THF, and their combination, administered together with MTX. In conclusion, trisomy 21 fibroblast cell lines showed a good response to the rescue effects of 5-formyl-THF and 5-methyl-THF on the MTX toxicity almost as normal cell lines.
Trisomy 21 causes Down syndrome (DS), the most common human genetic disorder and the leading genetic cause of intellectual disability. The alteration of one‐carbon metabolism was described as the possible metabolic cause of the intellectual disability development in subjects with DS. One of the biochemical pathways involved in the one‐carbon group transfer is the folate cycle. The cytotoxic drug methotrexate (MTX) is a folic acid (FA) analogue which inhibits the activity of dihydrofolate reductase enzyme involved in the one‐carbon metabolic cycle. Trisomy 21 cells are more sensitive to the MTX effect than euploid cells, and in 1986 Jérôme Lejeune and Coll. demonstrated that MTX was twice as toxic in trisomy 21 lymphocytes than in control cells. In the present work, the rescue effect on MTX toxicity mediated by FA and some of its derivatives, tetrahydrofolate (THF), 5‐formyl‐THF, and 5‐methyl‐THF, in both normal and trisomy 21 skin fibroblast cells, was evaluated. A statistically significant rescue effect was obtained by 5‐formyl‐THF, 5‐methyl‐THF, and their combination, administered together with MTX. In conclusion, trisomy 21 fibroblast cell lines showed a good response to the rescue effects of 5‐formyl‐THF and 5‐methyl‐THF on the MTX toxicity almost as normal cell lines. Alteration of one‐carbon metabolism might be a metabolic cause of intellectual disability in Down syndrome. Folate cycle is a one‐carbon group transfer pathway. The rescue effect on methotrexate (MTX) toxicity mediated by folates: folic acid, tetrahydrofolate (THF), 5‐formyl‐THF, and 5‐methyl‐THF, in both normal and trisomy 21 skin fibroblast cells was evaluated. A statistically significant rescue effect was obtained by 5‐formyl‐THF, 5‐methyl‐THF, and their combination, when administered with MTX.
Author Vitale, Lorenza
Cicchini, Elena
Piovesan, Allison
Caracausi, Maria
Lauriola, Mattia
Antonaros, Francesca
Serpieri, Valentina
Strippoli, Pierluigi
Cocchi, Guido
Locatelli, Chiara
Author_xml – sequence: 1
  givenname: Lorenza
  surname: Vitale
  fullname: Vitale, Lorenza
  organization: University of Bologna
– sequence: 2
  givenname: Valentina
  surname: Serpieri
  fullname: Serpieri, Valentina
  organization: University of Pavia
– sequence: 3
  givenname: Mattia
  surname: Lauriola
  fullname: Lauriola, Mattia
  organization: University of Bologna
– sequence: 4
  givenname: Allison
  surname: Piovesan
  fullname: Piovesan, Allison
  organization: University of Bologna
– sequence: 5
  givenname: Francesca
  surname: Antonaros
  fullname: Antonaros, Francesca
  organization: University of Bologna
– sequence: 6
  givenname: Elena
  surname: Cicchini
  fullname: Cicchini, Elena
  organization: University of Bologna
– sequence: 7
  givenname: Chiara
  surname: Locatelli
  fullname: Locatelli, Chiara
  organization: St. Orsola‐Malpighi Polyclinic
– sequence: 8
  givenname: Guido
  surname: Cocchi
  fullname: Cocchi, Guido
  organization: University of Bologna
– sequence: 9
  givenname: Pierluigi
  orcidid: 0000-0001-8769-8832
  surname: Strippoli
  fullname: Strippoli, Pierluigi
  email: pierluigi.strippoli@unibo.it
  organization: University of Bologna
– sequence: 10
  givenname: Maria
  surname: Caracausi
  fullname: Caracausi, Maria
  organization: University of Bologna
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30667057$$D View this record in MEDLINE/PubMed
BookMark eNp90ctu1DAUBmALFdFpYcELIEtsYJHW11yWaEQpqBIsYB2dOMcaj5J4sB212fUREI_YJ8HTKSwqYGVL_v4j6_wn5GjyExLykrMzzpg435rdmai5Yk_IirOmKlSpxRFZ5TdeNFrxY3IS45Yx1jRSPiPHkpVlxXS1Ij8v5xEmmoKLflyo4NS6LvhugJgiDRjNjHTEtPEp4A0kpMnfOEPRWjSJgk0YchohjTgleu3Shuq72x_7yDLkS8IUYLP0wVs_7PMw9ffC-jD-VTwnTy0MEV88nKfk28X7r-vL4urzh4_rd1eFkVqywgCvLLd1L0Bi19SAJfSihrIEbWoryo4rgUKzsgfeN0op0Wtdy0b3gJ0U8pS8OczdBf99xpja0UWDwwAT-jm2gleN4nlNdaavH9Gtn8OUf9cKIZpa1VrwrF49qLkbsW93wY0Qlvb3tjN4ewAm-BgD2j-Es3bfZJubbO-bzPb8kTUuQXJ-yttyw_8S127A5d-j20_rL4fELwhutYQ
CitedBy_id crossref_primary_10_3390_ijerph19052955
crossref_primary_10_2174_1874467212666191023120118
crossref_primary_10_1002_biof_2044
crossref_primary_10_1186_s40246_021_00325_4
crossref_primary_10_3389_fmed_2022_1006891
crossref_primary_10_1016_j_jpeds_2020_01_032
crossref_primary_10_1038_s41598_021_83379_7
Cites_doi 10.1006/cbir.2002.0861
10.1016/0006-291X(85)91641-9
10.1016/j.ygeno.2017.06.004
10.1203/00006450-198002000-00003
10.1007/978-3-7091-6721-2_4
10.3324/haematol.2016.142794
10.12659/MSM.899021
10.1111/j.1601-5223.1986.tb00654.x
10.1002/(SICI)1097-0223(199902)19:2<142::AID-PD486>3.0.CO;2-7
10.1002/jcp.1040830112
10.1093/hmg/6.12.2043
10.1016/j.stem.2012.08.004
10.1136/bmj.39465.544028.AE
10.1016/0024-3205(79)90276-5
10.1007/s00726-002-0337-1
10.1177/1947601911405841
10.7554/eLife.16220.036
10.3109/00498254.2013.845705
10.1093/database/baw153
10.1111/j.1365-2141.1995.tb08390.x
10.1007/BF00685122
10.1080/00365521.2017.1407440
10.4161/rna.23770
10.1080/01443615.2016.1250730
10.1007/s12032-011-0075-x
10.1002/pbc.20092
10.1016/j.freeradbiomed.2005.03.023
10.1371/journal.pone.0008394
10.1182/blood-2013-07-453480
10.1007/BF00444952
10.1002/jcp.25471
10.1186/1471-2350-7-24
10.1016/0014-4827(65)90219-3
10.1523/JNEUROSCI.3728-10.2010
10.1038/s41598-017-18456-x
10.14340/spp.2013.12R0005
10.1007/978-3-319-98788-0_10
10.1016/S0140-6736(86)92704-2
10.1172/JCI90253
10.1089/scd.2015.0061
10.1038/s41598-018-20834-y
10.3892/or.2016.5264
10.1080/10428190701824569
10.3389/fgene.2018.00125
ContentType Journal Article
Copyright 2019 Wiley Periodicals, Inc.
Copyright_xml – notice: 2019 Wiley Periodicals, Inc.
DBID AAYXX
CITATION
NPM
7TK
7U7
8FD
C1K
FR3
K9.
P64
RC3
7X8
DOI 10.1002/jcp.28140
DatabaseName CrossRef
PubMed
Neurosciences Abstracts
Toxicology Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
ProQuest Health & Medical Complete (Alumni)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
Genetics Abstracts
Technology Research Database
Toxicology Abstracts
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList Genetics Abstracts
PubMed
MEDLINE - Academic

CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Biology
EISSN 1097-4652
EndPage 15024
ExternalDocumentID 30667057
10_1002_jcp_28140
JCP28140
Genre article
Journal Article
GrantInformation_xml – fundername: Fondazione Umano Progresso
  funderid: 5421/2017‐III/13.13
– fundername: Fondazione Umano Progresso
  grantid: 5421/2017-III/13.13
GroupedDBID ---
-DZ
-~X
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
31~
33P
36B
3O-
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5GY
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
85S
8UM
930
9M8
A03
AAESR
AAEVG
AAHHS
AAHQN
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDPE
ABEFU
ABEML
ABIJN
ABJNI
ABPPZ
ABPVW
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACNCT
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHMBA
AIAGR
AITYG
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AUFTA
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMNLL
BMXJE
BNHUX
BQCPF
BROTX
BRXPI
BY8
CS3
D-E
D-F
DCZOG
DPXWK
DR1
DR2
DRFUL
DRSTM
DU5
EBD
EBS
EJD
EMB
EMOBN
F00
F01
F04
F5P
FEDTE
G-S
G.N
GNP
GODZA
H.T
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
H~9
IH2
IX1
J0M
JPC
KQQ
L7B
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M56
MEWTI
MK4
MRFUL
MRSTM
MSFUL
MSSTM
MVM
MXFUL
MXSTM
N04
N05
N9A
NEJ
NF~
NNB
O66
O9-
OHT
OIG
P2P
P2W
P2X
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
ROL
RWI
RWR
RX1
RYL
S10
SAMSI
SUPJJ
SV3
TN5
TWZ
UB1
UPT
V2E
V8K
VQP
W8V
W99
WBKPD
WH7
WIB
WIH
WIK
WJL
WNSPC
WOHZO
WQJ
WRC
WXSBR
WYB
WYISQ
X7M
XG1
XJT
XOL
XPP
XSW
XV2
Y6R
YQT
YZZ
ZGI
ZXP
ZZTAW
~IA
~WT
AAYXX
ADXHL
AETEA
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
NPM
PKN
7TK
7U7
8FD
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
C1K
FR3
K9.
P64
RC3
7X8
ID FETCH-LOGICAL-c3530-ca17f1f8d2a3eb98ae6ad28a66a5c8f26b142e2506da1d94442d558395daeb323
IEDL.DBID DR2
ISSN 0021-9541
1097-4652
IngestDate Fri Jul 11 02:56:43 EDT 2025
Mon Jul 21 01:54:19 EDT 2025
Wed Feb 19 02:25:44 EST 2025
Thu Apr 24 22:54:46 EDT 2025
Tue Jul 01 01:32:00 EDT 2025
Wed Jan 22 16:38:31 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords folates
methotrexate
fibroblasts
trisomy 21
one-carbon metabolism
Language English
License 2019 Wiley Periodicals, Inc.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3530-ca17f1f8d2a3eb98ae6ad28a66a5c8f26b142e2506da1d94442d558395daeb323
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-8769-8832
PMID 30667057
PQID 2229848521
PQPubID 1006363
PageCount 15
ParticipantIDs proquest_miscellaneous_2179417058
proquest_journals_2229848521
pubmed_primary_30667057
crossref_primary_10_1002_jcp_28140
crossref_citationtrail_10_1002_jcp_28140
wiley_primary_10_1002_jcp_28140_JCP28140
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate September 2019
2019-09-00
2019-Sep
20190901
PublicationDateYYYYMMDD 2019-09-01
PublicationDate_xml – month: 09
  year: 2019
  text: September 2019
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Hoboken
PublicationTitle Journal of cellular physiology
PublicationTitleAlternate J Cell Physiol
PublicationYear 2019
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References e_1_2_8_1_11_1
Lejeune J. (e_1_2_8_1_23_1) 1979; 22
e_1_2_8_1_36_1
e_1_2_8_1_57_1
e_1_2_8_1_34_1
e_1_2_8_1_55_1
e_1_2_8_1_53_1
e_1_2_8_1_30_1
e_1_2_8_1_51_1
e_1_2_8_1_9_1
Lejeune J. (e_1_2_8_1_24_1) 1959; 248
Lejeune J. (e_1_2_8_1_26_1) 1986; 29
Bottiglieri T. (e_1_2_8_1_3_1) 2010
e_1_2_8_1_27_1
e_1_2_8_1_29_1
e_1_2_8_1_48_1
e_1_2_8_1_22_1
e_1_2_8_1_47_1
e_1_2_8_1_45_1
e_1_2_8_1_43_1
e_1_2_8_1_20_1
e_1_2_8_1_41_1
Feaster W. W. (e_1_2_8_1_13_1) 1977; 29
Urakami K. (e_1_2_8_1_54_1) 1996; 7
e_1_2_8_1_7_1
e_1_2_8_1_5_1
Noguchi K. (e_1_2_8_1_33_1) 2018; 16
e_1_2_8_1_19_1
Pelleri M. C. (e_1_2_8_1_39_1) 2016; 25
e_1_2_8_1_15_1
e_1_2_8_1_17_1
e_1_2_8_1_38_1
e_1_2_8_1_12_1
e_1_2_8_1_35_1
e_1_2_8_1_58_1
e_1_2_8_1_14_1
e_1_2_8_1_56_1
e_1_2_8_1_31_1
e_1_2_8_1_10_1
e_1_2_8_1_52_1
e_1_2_8_1_8_1
Shane B. (e_1_2_8_1_46_1) 2010
e_1_2_8_1_28_1
Stover P. J. (e_1_2_8_1_50_1) 2010
e_1_2_8_1_25_1
e_1_2_8_1_44_1
e_1_2_8_1_21_1
e_1_2_8_1_40_1
Rosenblatt D. S. (e_1_2_8_1_42_1) 1982; 21
e_1_2_8_1_2_1
e_1_2_8_1_6_1
Steiner M. E. (e_1_2_8_1_49_1) 1982; 95
e_1_2_8_1_4_1
e_1_2_8_1_16_1
Necchi D. (e_1_2_8_1_32_1) 2015; 780
e_1_2_8_1_18_1
e_1_2_8_1_37_1
References_xml – volume: 7
  start-page: 82
  issue: 2
  year: 1996
  ident: e_1_2_8_1_54_1
  article-title: Analysis of amyloid precursor protein mRNAs in skin fibroblasts in Down’s syndrome
  publication-title: Dementia
– ident: e_1_2_8_1_58_1
  doi: 10.1006/cbir.2002.0861
– ident: e_1_2_8_1_7_1
  doi: 10.1016/0006-291X(85)91641-9
– ident: e_1_2_8_1_40_1
  doi: 10.1016/j.ygeno.2017.06.004
– ident: e_1_2_8_1_57_1
  doi: 10.1203/00006450-198002000-00003
– ident: e_1_2_8_1_43_1
  doi: 10.1007/978-3-7091-6721-2_4
– ident: e_1_2_8_1_55_1
  doi: 10.3324/haematol.2016.142794
– ident: e_1_2_8_1_16_1
  doi: 10.12659/MSM.899021
– ident: e_1_2_8_1_18_1
  doi: 10.1111/j.1601-5223.1986.tb00654.x
– ident: e_1_2_8_1_31_1
  doi: 10.1002/(SICI)1097-0223(199902)19:2<142::AID-PD486>3.0.CO;2-7
– volume: 16
  start-page: 1827
  issue: 2
  year: 2018
  ident: e_1_2_8_1_33_1
  article-title: The mitochondrial one‐carbon metabolic pathway is associated with patient survival in pancreatic cancer
  publication-title: Oncology Letters
– volume: 29
  start-page: 563
  issue: 6
  year: 1977
  ident: e_1_2_8_1_13_1
  article-title: Dosage effects for superoxide dismutase‐1 in nucleated cells aneuploid for chromosome 21
  publication-title: American Journal of Human Genetics
– ident: e_1_2_8_1_45_1
  doi: 10.1002/jcp.1040830112
– ident: e_1_2_8_1_4_1
  doi: 10.1093/hmg/6.12.2043
– start-page: pp. 355
  volume-title: Folate in health and disease
  year: 2010
  ident: e_1_2_8_1_3_1
– ident: e_1_2_8_1_28_1
  doi: 10.1016/j.stem.2012.08.004
– volume: 21
  start-page: 718
  issue: 3
  year: 1982
  ident: e_1_2_8_1_42_1
  article-title: Differential effects of folinic acid and glycine, adenosine, and thymidine as rescue agents in methotrexate‐treated human cells in relation to the accumulation of methotrexate polyglutamates
  publication-title: Molecular Pharmacology
– volume: 95
  start-page: 515
  issue: 2
  year: 1982
  ident: e_1_2_8_1_49_1
  article-title: Normal formation and repair of gamma‐radiation‐induced single and double strand DNA breaks in Down syndrome fibroblasts
  publication-title: Mutation Research/DNA Repair
– ident: e_1_2_8_1_12_1
  doi: 10.1136/bmj.39465.544028.AE
– ident: e_1_2_8_1_47_1
  doi: 10.1016/0024-3205(79)90276-5
– ident: e_1_2_8_1_9_1
  doi: 10.1007/s00726-002-0337-1
– ident: e_1_2_8_1_34_1
  doi: 10.1177/1947601911405841
– volume: 22
  start-page: 67
  issue: 2
  year: 1979
  ident: e_1_2_8_1_23_1
  article-title: Biochemical investigations and trisomy 21 (author’s transl)
  publication-title: Annales de génétique
– volume: 248
  start-page: 602
  issue: 4
  year: 1959
  ident: e_1_2_8_1_24_1
  article-title: Human chromosomes in tissue cultures
  publication-title: Comptes Rendus Hebdomadaires des Seances de l’Academie des Sciences
– volume: 25
  start-page: 2525
  year: 2016
  ident: e_1_2_8_1_39_1
  article-title: Systematic reanalysis of partial trisomy 21 cases with or without Down syndrome suggests a small region on 21q22.13 as critical to the phenotype
  publication-title: Human Molecular Genetics
– ident: e_1_2_8_1_52_1
  doi: 10.7554/eLife.16220.036
– ident: e_1_2_8_1_44_1
  doi: 10.3109/00498254.2013.845705
– ident: e_1_2_8_1_41_1
  doi: 10.1093/database/baw153
– ident: e_1_2_8_1_37_1
  doi: 10.1111/j.1365-2141.1995.tb08390.x
– ident: e_1_2_8_1_25_1
  doi: 10.1007/BF00685122
– ident: e_1_2_8_1_56_1
  doi: 10.1080/00365521.2017.1407440
– ident: e_1_2_8_1_11_1
  doi: 10.4161/rna.23770
– ident: e_1_2_8_1_29_1
  doi: 10.1080/01443615.2016.1250730
– ident: e_1_2_8_1_8_1
  doi: 10.1007/s12032-011-0075-x
– ident: e_1_2_8_1_53_1
  doi: 10.1002/pbc.20092
– ident: e_1_2_8_1_19_1
  doi: 10.1016/j.freeradbiomed.2005.03.023
– ident: e_1_2_8_1_2_1
  doi: 10.1371/journal.pone.0008394
– ident: e_1_2_8_1_17_1
  doi: 10.1182/blood-2013-07-453480
– volume: 29
  start-page: 16
  issue: 1
  year: 1986
  ident: e_1_2_8_1_26_1
  article-title: Metabolism of monocarbons and trisomy 21: Sensitivity to methotrexate
  publication-title: Annales de génétique
– ident: e_1_2_8_1_35_1
  doi: 10.1007/BF00444952
– ident: e_1_2_8_1_6_1
  doi: 10.1002/jcp.25471
– ident: e_1_2_8_1_27_1
  doi: 10.1186/1471-2350-7-24
– ident: e_1_2_8_1_10_1
  doi: 10.1016/0014-4827(65)90219-3
– start-page: pp. 49
  volume-title: Folate in Health and Disease
  year: 2010
  ident: e_1_2_8_1_50_1
– start-page: pp. 1
  volume-title: Folate in health and disease
  year: 2010
  ident: e_1_2_8_1_46_1
– ident: e_1_2_8_1_15_1
  doi: 10.1523/JNEUROSCI.3728-10.2010
– ident: e_1_2_8_1_20_1
  doi: 10.1038/s41598-017-18456-x
– ident: e_1_2_8_1_51_1
  doi: 10.14340/spp.2013.12R0005
– ident: e_1_2_8_1_21_1
  doi: 10.1007/978-3-319-98788-0_10
– ident: e_1_2_8_1_36_1
  doi: 10.1016/S0140-6736(86)92704-2
– volume: 780
  start-page: 15
  year: 2015
  ident: e_1_2_8_1_32_1
  article-title: Defective DNA repair and increased chromatin binding of DNA repair factors in Down syndrome fibroblasts
  publication-title: Mutation Research/DNA Repair
– ident: e_1_2_8_1_22_1
  doi: 10.1172/JCI90253
– ident: e_1_2_8_1_48_1
  doi: 10.1089/scd.2015.0061
– ident: e_1_2_8_1_5_1
  doi: 10.1038/s41598-018-20834-y
– ident: e_1_2_8_1_30_1
  doi: 10.3892/or.2016.5264
– ident: e_1_2_8_1_14_1
  doi: 10.1080/10428190701824569
– ident: e_1_2_8_1_38_1
  doi: 10.3389/fgene.2018.00125
SSID ssj0009933
Score 2.3377204
Snippet Trisomy 21 causes Down syndrome (DS), the most common human genetic disorder and the leading genetic cause of intellectual disability. The alteration of...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 15010
SubjectTerms Biotechnology
Carbon
Carbon cycle
Cell lines
Cytotoxicity
Dihydrofolate reductase
Down's syndrome
Fibroblasts
folates
Folic acid
Genetic disorders
Intellectual disabilities
Lymphocytes
Metabolism
Methotrexate
one‐carbon metabolism
Skin
Statistical analysis
Tetrahydrofolic acid
Toxicity
Trisomy
trisomy 21
Title Human trisomy 21 fibroblasts rescue methotrexate toxic effect after treatment with 5‐methyl‐tetrahydrofolate and 5‐formyl‐tetrahydrofolate
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjcp.28140
https://www.ncbi.nlm.nih.gov/pubmed/30667057
https://www.proquest.com/docview/2229848521
https://www.proquest.com/docview/2179417058
Volume 234
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bS91AEB5EEHxp66XtabWsRUpfcjSb3Zw9-CRSEcFSSgUfCmGv0NbmiGcPePrUnyD-xP6SzmwuYqtQ-hbIbDbZzMx-M5l8A7AtXU7MWSbzchwyobTJDA8-40bYwsgQXCL1OXlfHp2K4zN5tgB73b8wDT9En3Ajy0j-mgxcm-nOLWnoV3sx5MTXhP6XarUIEH28pY4at23kUwmCFHnHKrTLd_qRd_eivwDmXbyaNpzDx_C5u9WmzuTbcBbN0P74g8XxP5_lCTxqgSjbbzRnBRZ8vQpr-zUG4d_n7A1LpaEp574KS03Hyvka3KSkP4vUuRDFeM4CTjwxiMHjlGHobmeepa7U8dJfIY5lcXL1xbKmbISljuSsL25nlAVm8tfPaxoyP8eD6CO6v7nD7QGDbhyva5ckCFzfK7EOp4fvPh0cZW1bh8wWstjNrM5HIQ_KcV14M1bal9pxpctSS6sCLykv5RGalU7nbiyE4E5KBHLSaQz9efEUFutJ7Z8Dc3IUtERlwzBJ-DDCa3Fj0MmgW1K5DAN4273gyrac59R647xq2Jp5hStfpZUfwOte9KIh-rhPaKPTkqq19WlFHdGVUIiDBrDVn0YrpU8vuvaTGcqQ3yPmIjWAZ4129bMUVGeMsBlvNunIw9NXxwcf0sGLfxd9CcuI8dqyuA1YjJczv4k4KppXyWB-A9KAH38
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bahRBEC1iRPTFS2J0NWorIr7MJtPTPdsLvoRgWGMSRBLIiwx9BTXOhqQXsj75CeIn-iVW9VxCNIL4NrDV27OzVdWnamvPAXguXU7MWSbzchwyobTJDA8-40bYwsgQXCL12d0rJwdi-1AeLsCr7r8wDT9E33CjyEj5mgKcGtJr56yhn-zxkBNh0xW4SoreqaB6f04eNW6F5NMQghR5xyu0ztf6pRdPoz8g5kXEmo6crVvwobvZZtLk83AWzdB-_Y3H8X8_zW242WJRttE4zx1Y8PUSLG_UWId_mbMXLE2Hprb7ElxrRCvny_Aj9f1ZJPFCNOM5C7jz1CAMj6cMq3c78ywJU8cTf4ZQlsXp2UfLmskRlkTJWT_fzqgRzOTPb99pyfwIL6KPmAHnDk8IrLtxva5dsiB8fanFXTjYer2_OclaZYfMFrJYz6zORyEPynFdeDNW2pfacaXLUkurAi-pNeURnZVO524shOBOSsRy0mms_nmxAov1tPb3gTk5Clqiv2GlJHwY4XtxYzDPYGZSuQwDeNl9w5Vtac9JfeOoagibeYVPvkpPfgDPetPjhuvjMqPVzk2qNtxPKxJFV0IhFBrA0_5lDFT69UXXfjpDG0p9RF6kBnCvca9-l4JGjRE5480mJ_n79tX25rt08eDfTZ_A9cn-7k6182bv7UO4gZCvnZJbhcV4MvOPEFZF8zhFzy-bIyOa
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fT9RAEJ8gROOLIoiegq6GGF96d93u9vbCEwEuiEoIkYQHk2b_Jir2LrCXcD7xEYgf0U_C7PYPQTExvjXpbLfdzsz-Zjr9DcA6N2lgzlKJ5UOXMCFVoqizCVVMZ4o7ZyKpz8f9fPeI7R3z4znYaP6Fqfgh2oRbsIzor4OBT4zrXZOGftWTLg18TXdggeV9EVR6-_CaO2pY95GPNQicpQ2tUJ_22qE3N6M_EOZNwBp3nNFD-Nzca1Vo8q079aqrf_xG4_ifD7MID2okSjYr1XkEc7ZcguXNEqPw7zPyhsTa0Jh0X4K7VcvK2TL8jFl_4kPrQhSjKXE48VghCPdnBGN3PbUktqX2p_YcgSzx4_MvmlR1IyS2JCdtdTsJaWDCf11chiGzEzzw1qP_mxncHzDqxvGyNFEioOtbJR7D0Wjn09ZuUvd1SHTGs36iZTpwqROGysyqoZA2l4YKmeeSa-FoHhJTFrFZbmRqhowxajhHJMeNxNifZiswX45L-xSI4QMnOWobxknMugFeiyqFXgb9kki568Db5gUXuiY9D703ToqKrpkWuPJFXPkOvG5FJxXTx21Cq42WFLWxnxWhJbpgAoFQB161p9FMw7cXWdrxFGWC4wvURaIDTyrtamfJQqEx4ma82agjf5--2Ns6iAfP_l30Jdw72B4VH97tv38O9xHv1SVyqzDvT6d2DTGVVy-i7VwBRqgiUg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Human+trisomy+21+fibroblasts+rescue+methotrexate+toxic+effect+after+treatment+with+5%E2%80%90methyl%E2%80%90tetrahydrofolate+and+5%E2%80%90formyl%E2%80%90tetrahydrofolate&rft.jtitle=Journal+of+cellular+physiology&rft.au=Vitale%2C+Lorenza&rft.au=Serpieri%2C+Valentina&rft.au=Lauriola%2C+Mattia&rft.au=Piovesan%2C+Allison&rft.date=2019-09-01&rft.issn=0021-9541&rft.eissn=1097-4652&rft.volume=234&rft.issue=9&rft.spage=15010&rft.epage=15024&rft_id=info:doi/10.1002%2Fjcp.28140&rft.externalDBID=10.1002%252Fjcp.28140&rft.externalDocID=JCP28140
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9541&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9541&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9541&client=summon